- Open Access
Correction to: Mesenchymal stem cells in the treatment of severe COVID-19
Translational Medicine Communications volume 6, Article number: 19 (2021)
Correction to: Transl Med Commun 6, 16 (2021)
Following publication of the original article , the authors reported an error in the list of affiliations and requested to remove affiliation 2 “University of California San Diego Health System, Translational Neurosciences and Neurotherapeutics, Santa Monica, CA 90404, USA.”
The original article  has been updated.
Kesari S, Kasper GC, Verkh L, et al. Mesenchymal stem cells in the treatment of severe COVID-19. Transl Med Commun. 2021;6:16. https://doi.org/10.1186/s41231-021-00095-0.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kesari, S., Kasper, G.C., Verkh, L. et al. Correction to: Mesenchymal stem cells in the treatment of severe COVID-19. transl med commun 6, 19 (2021). https://doi.org/10.1186/s41231-021-00098-x